[1]
|
李小芬, 吴红梅, 王祥培. UPLC法测定香蕉、皇帝蕉皮及其果肉中羽扇豆酮含量[J]. 食品科学, 2017, 38(22): 156-161.
|
[2]
|
李小芬, 王远敏, 王祥培, 等. HPLC法测定5个采收期香蕉、野蕉、皇帝蕉果皮中羽扇豆酮[J]. 中成药, 2017, 39(12): 2630-2632.
|
[3]
|
Wu, H., Xu, F., Hao, J., et al. (2015) Antihyperglycemic Activity of Banana (Musa nana Lour.) Peel and Its Active Ingredients in Alloxan-Induced Diabetic Mice. 3rd International Conference on Material, Mechanical and Manufacturing Engineering (IC3ME 2015), Guangzhou, 27-28 June 2015, 231-238. https://doi.org/10.2991/ic3me-15.2015.44
|
[4]
|
王妙飞, 陈娇婷, 张兆峰, 等. 香蕉皮中总黄酮的提取工艺[J]. 光谱实验室, 2012, 29(4): 2204-2207.
|
[5]
|
Shadma, A., Sundaram, S. and Rai, G.K. (2014) Nutraceutical Application and Value Addition of Banana Peel: A Review. International Journal of Pharmacy and Pharmaceutical Sciences, 6, 81-85.
|
[6]
|
Bhaskar, J.J., Shobha, M.S., Sambaiah, K., et al. (2011) Beneficial Effects of Banana (Musa sp. var. elakki bale) Flower and Pseudostem on Hyperglycemia and Advanced Glycation End-Products (AGEs) in Streptozotocin-Induced Diabetic Rats. Journal of Physiology and Biochemistry, 67, 415-425. https://doi.org/10.1007/s13105-011-0091-5
|
[7]
|
梁盛年, 段志芳, 方旺标, 等. 香蕉皮化学成分的预试验及抑菌初探[J]. 食品科技, 2007, 32(1): 108-111.
|
[8]
|
李仁茂, 陈蓉. 萧志成. 粤西地区四种香蕉皮的成份分析[J]. 湛江师范学院学报, 2001, 22(6): 42-45.
|
[9]
|
翁竞玉, 陈俊, 刘坤玲, 等. 天然黄酮类化合物防治糖尿病肾病的研究进展[J]. 药学研究, 2018, 37(10): 593-596.
|
[10]
|
钟羚君, 谢治深, 徐晓军. 天然小分子化合物改善糖尿病肾病的研究进展[J]. 药学进展, 2017, 41(10): 742-748.
|
[11]
|
Navghare, V. and Dhawale, S. (2016) Suppression of Type-II Diabetes with Dyslipidemia and Nephropathy by Peels of Musa Cavendish Fruit. Indian Journal of Clinical Biochemistry, 31, 380-389. https://doi.org/10.1007/s12291-016-0548-y
|
[12]
|
王妙飞, 程庚金生, 黄浩, 等. 香蕉皮总黄酮对糖尿病及其并发症的影响[J]. 食品工业科技, 2015, 36(2): 362-363.
|
[13]
|
Wu, H., Xu, F., Huang, X., et al. (2023) Lupenone Improves Type 2 Diabetic Nephropathy by Regulating NF-κB Pathway-Mediated Inflammation and TGF-β1/Smad/CTGF-Associated Fibrosis. Phytomedicine, 118, Article ID: 154959. https://doi.org/10.1016/j.phymed.2023.154959
|
[14]
|
黄旭龙. 芭蕉根有效成分的替代资源和防治2型DN炎症途径的作用机制研究[D]: [硕士学位论文]. 贵阳: 贵州中医药大学, 2020.
|
[15]
|
张玲玲. 基于肾纤维化角度研究羽扇豆酮防治2型DN的作用及分子机制[D]: [硕士学位论文]. 贵阳: 贵州中医药大学, 2020.
|
[16]
|
Tao, W., Xu, X., Wang, X., et al. (2013) Network Pharmacology-Based Prediction of the Active Ingredients and Potential Targets of Chinese Herbal Radix Curcumae Formula for Application to Cardiovascular Disease. Journal of Ethnopharmacology, 145, 1-10. https://doi.org/10.1016/j.jep.2012.09.051
|
[17]
|
Hopkins, A.L. (2008) Network Pharmacology: The Next Paradigm in Drug Discovery. Nature Chemical Biology, 4, 682-690. https://doi.org/10.1038/nchembio.118
|
[18]
|
王旭焘, 潘定一, 郭玮, 等. 阿魏酸对糖尿病大鼠肾脏足细胞nephrin、podocin蛋白表达的影响[J]. 中国应生理学杂志, 2017, 33(6): 564-567.
|
[19]
|
孟徐兵, 梁伟时, 薛宁, 等. 芦丁延缓糖尿病并发症进程的研究现状[J]. 中国高新科技, 2019(2): 42-44.
|
[20]
|
Zhang, J., Yang, S., Li, H., et al. (2017) Naringin Ameliorates Diabetic Nephropathy by Inhibiting NADPH Oxidase 4. European Journal of Pharmacology, 804, 1-6. https://doi.org/10.1016/j.ejphar.2017.04.006
|
[21]
|
Hong, Y., Wang, J., Sun, W., et al. (2023) Gallic Acid Improves the Metformin Effects on Diabetic Kidney Disease in Mice. Renal Failure, 45, Article ID: 2183726. https://doi.org/10.1080/0886022X.2023.2183726
|
[22]
|
宗阳, 丁美林, 贾可可, 马世堂, 等. 基于网络药理学和分子对接法探寻达原饮治疗新型冠状病毒肺炎(COVID-19)活性化合物的研究[J]. 中草药, 2020, 51(4): 836-844.
|
[23]
|
Jiang, X., Yu, J., Wang, X., et al. (2019) Quercetin Improves Lipid Metabolism via SCAP-SREBP2-LDLr Signaling Pathway in Early Stage Diabetic Nephropathy. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 827-839. https://doi.org/10.2147/DMSO.S195456
|
[24]
|
Du, L., et al. (2019) Quercetin Inhibited Mesangial Cell Proliferation of Early Diabetic Nephropathy through the Hippo Pathway. Pharmacological Research, 146, Article ID: 104320. https://doi.org/10.1016/j.phrs.2019.104320
|
[25]
|
Zhou, Q., et al. (2014) ( )-Catechin Ameliorates Diabetic Nephropathy by Trapping Methylglyoxal in Type 2 Diabetic Mice. Molecular Nutrition and Food Research, 58, 2249-2260. https://doi.org/10.1002/mnfr.201400533
|
[26]
|
Samarghandian, S., Azimi-Nezhad, M. and Farkhondeh, T. (2017) Catechin Treatment Ameliorates Diabetes and Its Complications in Streptozotocin-Induced Diabetic Rats. Dose-Response, 15, No. 1. https://doi.org/10.1177/1559325817691158
|
[27]
|
张云霞. 阿魏酸及其衍生物治疗糖尿病肾病的疗效观察[J]. 中国医药指南, 2017, 15(5): 76-77.
|
[28]
|
Roy, S., Ahmed, F., Banerjee, S., et al. (2016) Naringenin Ameliorates Streptozotocin-Induced Diabetic Rat Renal Impairment by Downregulation of TGF-β1 and IL-1 via Modulation of Oxidative Stress Correlates with Decreased Apoptotic Events. Pharmaceutical Biology, 54, 1616-1627. https://doi.org/10.3109/13880209.2015.1110599
|
[29]
|
Ahad, A., Ahsan, H., Mujeeb, M., et al. (2015) Gallic Acid Ameliorates Renal Functions by Inhibiting the Activation of p38 MAPK in Experimentally Induced Type 2 Diabetic Rats and Cultured Rat Proximal Tubular Epithelial Cells. Chemico-Biological Interactions, 240, 292-303. https://doi.org/10.1016/j.cbi.2015.08.026
|
[30]
|
余红, 石明隽, 肖瑛, 等. 丹芪合剂下调糖尿病肾病大鼠肾组织Akt1的表达[J]. 中国实验方剂学杂志, 2013, 19(7): 259-262.
|
[31]
|
Liu, Y. (2010) New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis. Journal of the American Society of Nephrology, 21, 212-222. https://doi.org/10.1681/ASN.2008121226
|
[32]
|
吴琼皎. 2型DN患者血清VEGF、IL-6及TNF-α水平的检测与意义[J]. 中国医药科学, 2014, 4(20): 136-138.
|
[33]
|
Carranza, K., Veron, D., Cercado, A., et al. (2015) Cellular and Molecular Aspects of Diabetic Nephropathy; the Role of VEGF-A. Nefrología, 35, 131-138. https://doi.org/10.1016/j.nefro.2015.05.013
|
[34]
|
尹德海, 梁晓春. 从肾小球系膜细胞表型转化谈中医药防治糖尿病肾病机制研究思路[J]. 中国中医药信息杂志, 2008, 15(6): 90-91.
|
[35]
|
Taylor, E.S., Pol‐Fachin, L., Lins, R.D., et al. (2017) Conformational Stability of the Epidermal Growth Factor (EGF) Receptor as Influenced by Glycosylation, Dimerization and EGF Hormone Binding. Proteins: Structure, Function, and Bioinformatics, 85, 561-570. https://doi.org/10.1002/prot.25220
|
[36]
|
Ju, W., Nair, V., Smith, S., et al. (2015) Tissue Transcriptome-Driven Identification of Epidermal Growth Factor as a Chronic Kidney Disease Biomarker. Science Translational Medicine, 7, 316ra193.
|
[37]
|
Kashihara, N., Haruna, Y.K., Kondeti, V., et al. (2010) Oxidative Stress in Diabetic Nephropathy. Current Medicinal Chemistry, 17, 4256-4269. https://doi.org/10.2174/092986710793348581
|
[38]
|
Brosius, F.C. (2003) Trophic Factors and Cytokines in Early Diabetic Glomerulopathy. Experimental Diabesity Research, 4, 225-233. https://doi.org/10.1155/EDR.2003.225
|
[39]
|
Ramasamy, R., Yan, S.F. and Schmidt, A.M. (2011) Receptor for AGE (RAGE): Signaling Mechanisms in the Pathogenesis of Diabetes and Its Complications. Annals of the New York Academy of Sciences, 1243, 88-102. https://doi.org/10.1111/j.1749-6632.2011.06320.x
|
[40]
|
Yamagishi, S. (2011) Role of Advanced Glycation End Products (AGEs) and Receptor for AGEs (RAGE) in Vascular Damage in Diabetes. Experimental Gerontology, 46, 217-224. https://doi.org/10.1016/j.exger.2010.11.007
|
[41]
|
马楠, 刘艳姝, 刘文思, 等. HIF-1α、VEGF信号通路在糖尿病肾病中的作用研究进展[J]. 广东化工, 2020, 47(23): 63-70.
|
[42]
|
危正南, 李涛, 张庆红, 等. MIF、TLR4、TNF-α水平在糖尿病肾病患者中的变化及其临床意义[J]. 疑难病杂志, 2016, 15(2): 165-168.
|
[43]
|
Mohamed, R., Jayakumar, C., Chen, F., et al. (2016) Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis. Journal of the American Society of Nephrology, 27, 745-765. https://doi.org/10.1681/ASN.2014111136
|
[44]
|
张洪江, 凃影叶, 杜飞, 等. TGF-β参与糖尿病肾病的发生发展的机制研究现状[J]. 生命科学, 2020, 32(2): 179-187.
|
[45]
|
于翔, 戴铭卉, 刘猛, 等. 通腑泄浊法对慢性肾脏病大鼠TGF-β1/p38MAPK信号通路的调节作用[J]. 中成药, 2019, 41(5): 1000-1005.
|
[46]
|
Jin, M., Chadban, S.J., Zhao, C.Y., et al. (2014) TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy. PLOS ONE, 9, e97985. https://doi.org/10.1371/journal.pone.0097985
|
[47]
|
任凌燕, 朱鸣, 朱华艳, 等. 雷公藤甲素通过调控Toll-样受体(TLR)/核因子κB(NF-κB)信号通路对糖尿病肾病模型小鼠足细胞的作用研究[J]. 浙江中西医结合杂志, 2020, 30(3): 191-195.
|
[48]
|
马可可, 鞠营辉, 陈清青, 等. 黄芪甲苷对2型糖尿病肾病大鼠肾组织PI3K/Akt/FoxO1信号调控的影响[J]. 中国实验方剂学杂志, 2019, 25(2): 74-81.
|